NCT07212530 EmoTIChealth: Promoting Adolescent Health Through a Serious Game.
| NCT ID | NCT07212530 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Valencia |
| Condition | Type 1 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2027-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2025-12-01 with a primary completion date of 2027-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The intervention program targets adolescents between 12 and 16 years of age. The intervention program is designed for adolescents during a critical developmental stage marked by significant life transitions, where building strong personal resources and receiving psychological support is essential to foster socioemotional skills and overall well-being. The serious game aims to promote psycho-emotional health in the general adolescent population, supporting healthy development and preventing future emotional difficulties. At the same time, it incorporates specific modules for adolescents living with chronic conditions such as asthma, food allergy, type 1 diabetes, and allergic rhinitis, who may face additional risks of psychological challenges that can complicate treatment and prognosis. By combining universal health promotion with tailored support, the program addresses both the needs of healthy adolescents and those with chronic illnesses. The platform integrates digital and technological tools for dynamic and personalized intervention. Artificial intelligence adapts activities and feedback to each participant's socio-demographic profile and evolving needs, this supports directly in participants' daily lives and natural environments, making the experience more relevant and impactful. The serious game, proven effective in engaging young people, goes beyond traditional psychoeducation by creating an interactive environment where adolescents develop socio-emotional competencies, resilience, and health-related knowledge. Through its six thematic areas, the game promotes overall well-being and healthy habits, while its condition-specific modules provide targeted guidance and coping strategies for asthma, food allergies, type 1 diabetes, and allergic rhinitis.
Eligibility Criteria
Inclusion Criteria: * Informed consent by parents/guardians and participants. * Aged between 12 and 16 years old Exclusion Criteria: * No access to internet or new technologies * Not a Spanish speaker.
Contact & Investigator
Marián Pérez-Marín, PHD
PRINCIPAL INVESTIGATOR
Universitat de Valencia
Frequently Asked Questions
Who can join the NCT07212530 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 16 Years, studying Type 1 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07212530 currently recruiting?
Yes, NCT07212530 is actively recruiting participants. Contact the research team at marian.perez@uv.es for enrollment information.
Where is the NCT07212530 trial being conducted?
This trial is being conducted at Valencia, Spain.
Who is sponsoring the NCT07212530 clinical trial?
NCT07212530 is sponsored by University of Valencia. The principal investigator is Marián Pérez-Marín, PHD at Universitat de Valencia. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.